Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBCBS Illinois Oral Cancer Testing Update | OpenPay…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - IllinoisPolicy RPLAB032

    Oral Cancer Screening and Testing

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Illinois Policy RPLAB032 alerts

    Get alerted when Policy RPLAB032 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Reimbursement for laboratory testing used to establish HPV tumor status in certain head and neck cancers and for tests intended to screen for, detect, or diagnose oral cancer, subject to plan documents and provider contracts.

    Policy Summary
    PayerBlue Cross Blue Shield - Illinois
    PolicyOral Cancer Screening and Testing
    Policy CodePolicy RPLAB032
    Change TypeClarification and code updates
    Effective DateDecember 4, 2026
    Next Review DateN/A
    Key ActionReview applicable plan documents because lab management reimbursement requirements may vary by product.
    SourceLink
    POLICY UPDATE CHANGES

    The policy clarified that mRNA CancerDetect and OmniPathology oropharyngeal HPV PCR testing are not reimbursable.

    Procedure code 0296U was added to the policy's listed procedure codes.

    Procedure codes 81599, 82397, 88341, and 88342 were removed from the policy.

    The policy references were revised.

    2Potentially reimbursable HPV tumor-status testing methods
    3Nonreimbursable oral cancer testing categories

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    5Procedure codes listed in the policy
    4Procedure codes removed in policy history

    Coverage Criteria

    Potentially Reimbursable HPV Tumor-Status Testing

    Testing may be reimbursable when ALL of the following criteria are met:

    ALL of the following

    • Individual has ONE of the following conditions

      • Oropharyngeal squamous cell carcinoma
      • Metastatic squamous cell carcinoma of unknown primary origin in a cervical lymph node
    • Testing uses ONE of the following methods to establish HPV tumor status

      • High-risk HPV mRNA expression testing for HPV E6/E7
      • Immunohistochemistry for p16 expression

    Nonreimbursable Oral Cancer Screening and Diagnostic Testing

    The following testing is not reimbursable when performed to screen for, detect, or diagnose oral cancer:

    ANY of the following

    • Noninvasive tests designed to screen for, detect, or diagnose oral cancer, including mRNA CancerDetect™ and the OmniPathology Oropharyngeal HPV PCR Test
    • Salivary biomarker testing, including testing for peptides, proteins, nucleic acids, or metabolites
    • Panels that incorporate genetic risk factors with nongenetic biomarkers
    • Detection of HPV using an oropharyngeal swab

    Procedure Codes

    Listed HPV testing procedure codesCPT
    87624HPV high-risk type, pooled result
    87625HPV types 16 and 18 only
    87626HPV separate high-risk typing and pooled result
    Listed oral/oropharyngeal cancer molecular testCPTNot Covered
    0296UOncology oral and/or oropharyngeal cancer, 20 molecular features
    Listed oropharyngeal HPV swab testCPTNot Covered
    0429UHPV oropharyngeal swab, 14 high-risk types

    Billing and Documentation Requirements

    Documentation Required

    Submit accurate documentation and coding

    Submit accurate documentation of the services performed and claims using valid code combinations from Health Insurance Portability and Accountability Act-approved code sets. Code services appropriately according to applicable industry-standard coding guidelines.

    Billing Rule

    Prepare for claim review

    Claims are subject to code-edit protocols and claim review, including benefit coverage terms, provider contract language, medical and reimbursement policies, and coding software logic. Upon request, submit any additional supporting documentation.

    Policy Summary
    PayerBlue Cross Blue Shield - Illinois
    PolicyOral Cancer Screening and Testing
    Policy CodePolicy RPLAB032
    Change TypeClarification and code updates
    Effective DateDecember 4, 2026
    Next Review DateN/A
    Key ActionReview applicable plan documents because lab management reimbursement requirements may vary by product.
    SourceLink
    On This Page
    Coverage CriteriaProcedure CodesBilling and Documentation Requirements
    Documentation Required

    Review product-specific requirements

    Review the applicable Plan documents for eligible coverage before submitting services, because laboratory management reimbursement requirements may vary by product. If a Plan document conflicts with this reimbursement policy, the Plan document governs; provider contracts govern in the event of a conflict with the policy.